Use Of Letermovir For Salvage Therapy For Resistant Cytomegalovirus In A Pediatric Hematopoietic Stem Cell Transplant Recipient
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY(2020)
摘要
We present here the first published use of letermovir for the treatment of resistant cytomegalovirus (CMV) in a pediatric patient. A 14-year-old girl underwent a double unrelated umbilical cord blood transplantation to treat her sickle cell disease (hemoglobin SS) and developed ganciclovir-resistant CMV DNAemia with end-organ involvement that was treated successfully with a combination of foscarnet and letermovir. After she was transitioned to letermovir monotherapy for secondary prophylaxis, she developed recurrent DNAemia with laboratory-confirmed ganciclovir, foscarnet, and letermovir resistance.
更多查看译文
关键词
cytomegalovirus (CMV), antiviral resistance, letermovir, hematopoietic stem cell transplant
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要